1. Home
  2. HUBB vs DGX Comparison

HUBB vs DGX Comparison

Compare HUBB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hubbell Inc

HUBB

Hubbell Inc

N/A

Current Price

$484.63

Market Cap

25.4B

Sector

Technology

ML Signal

N/A

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

N/A

Current Price

$236.32

Market Cap

23.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUBB
DGX
Founded
1888
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4B
23.2B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
HUBB
DGX
Price
$484.63
$236.32
Analyst Decision
Buy
Buy
Analyst Count
8
13
Target Price
$517.88
$214.38
AVG Volume (30 Days)
500.4K
994.0K
Earning Date
04-30-2026
04-21-2026
Dividend Yield
1.04%
1.82%
EPS Growth
15.10
13.78
EPS
3.41
5.08
Revenue
$5,844,600,000.00
$11,035,000,000.00
Revenue This Year
$10.41
$7.53
Revenue Next Year
$5.49
$3.77
P/E Ratio
$146.23
$45.64
Revenue Growth
3.84
11.78
52 Week Low
$403.82
$166.75
52 Week High
$565.50
$237.78

Technical Indicators

Market Signals
Indicator
HUBB
DGX
Relative Strength Index (RSI) 47.25 76.83
Support Level $462.95 $190.42
Resistance Level $491.11 N/A
Average True Range (ATR) 16.22 6.73
MACD 0.48 2.57
Stochastic Oscillator 56.97 89.99

Price Performance

Historical Comparison
HUBB
DGX

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, in electrical substations, and in commercial and industrial buildings. The company's primary operations are in the United States, where around 90% of revenue is derived.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: